
Senior Pharmacovigilance Specialist, Regulatory Intelligence and Submissions
Posted 4 days ago

Posted 4 days ago
This is a fully remote position, open to applicants in United States, +3 more countries.
• Oversee and track expedited and non-expedited Individual Case Safety Report (ICSR) submissions and exchanges.
• Ensure adherence to global pharmacovigilance reporting standards and internal protocols.
• Conduct monthly reconciliation activities for ICSRs with clients and safety partners.
• Assist with gateway-to-gateway testing for submissions to health authorities and exchanges with safety partners.
• Aid in the investigation, documentation, and resolution of issues related to submissions and CAPAs.
• Produce Argus-based line listings and summary tabulations for periodic safety reports.
• Help in the creation, validation, and quality review of custom reports and reporting outputs.
• Support the establishment, verification, and upkeep of periodic reporting needs across global markets.
• Coordinate periodic report submissions in alignment with local regulatory standards.
• Enhance pharmacovigilance reporting services and operational excellence.
• Research, gather, and maintain global pharmacovigilance reporting requirements.
• Perform monthly regulatory surveillance and impact assessments.
• Assist with regulatory intelligence tools, mailboxes, tickets, queries, and ad hoc projects.
• Provide insights on evolving pharmacovigilance regulations and reporting responsibilities.
• Conduct Performance Qualification (PQ) testing for Argus upgrades, patches, and custom developments.
• Support the implementation and validation of territory-specific and custom E2B profiles.
• Engage in data migration testing and enhancements related to submissions systems.
• Contribute to initiatives aimed at improving efficiency, quality, and system performance.
• Prepare and maintain xEVMPD submissions, updates, removals, and new product entries.
• Conduct peer reviews and ensure quality control of xEVMPD submissions.
• Assist with bulk updates, QPPV changes, master file location updates, and registrations for developmental products.
• A high school diploma is mandatory.
• A post-secondary qualification in a life sciences field is preferred.
• Relevant professional experience in pharmacovigilance regulatory submissions or regulatory intelligence will also be taken into account.
• A minimum of 3 years of experience with pharmacovigilance safety databases is required.
• Preference will be given to candidates with experience in safety reporting, ICSR submissions, E2B exchanges, and regulatory compliance activities.
• Experience with Oracle Argus Safety or similar safety databases is highly desirable.
• Familiarity with xEVMPD and global pharmacovigilance regulations is advantageous.
• A strong attention to detail and commitment to quality is essential.
• Excellent verbal and written communication skills are required.
• Strong organizational and problem-solving skills are necessary.
• Capacity to manage multiple priorities and adapt to shifting business needs is important.
• Ability to work independently while effectively collaborating within cross-functional and global teams is essential.
• Proficiency in Microsoft Office applications, including Outlook, Word, and Excel, is required.
• Collaborate with a global team of pharmacovigilance and regulatory specialists.
• Gain insights into international safety reporting requirements and interactions with health authorities.
• Contribute to impactful projects that support patient safety and regulatory compliance on a global scale.
• Develop expertise across submissions, regulatory intelligence, testing, and pharmacovigilance systems.
• Hybrid working arrangements are encouraged for new hires living within a reasonable commuting distance from an office, as agreed upon with the manager.
• Work in an Equal Opportunity Employer environment committed to diversity, equity, and inclusion.
biBerk Business Insurance
Doppel
PingWind Inc. (SDVOSB)
The Standard
Get handpicked remote jobs straight to your inbox weekly.